Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway

Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway

Abstract Background Cerebral ischemia is the second-leading cause of death and the main cause of permanent adult disabilities worldwide. Qingkailing (QKL) injection, a patented Chinese medicine approved by the China Food and Drug Administration, has been widely used in clinical practice to treat cer...

Full description

Bibliographic Details
Main Authors: Chongyang Ma, Xueqian Wang, Tian Xu, Xue Yu, Shuang Zhang, Shuling Liu, Yushan Gao, Shuning Fan, Changxiang Li, Changming Zhai, Fafeng Cheng, Qingguo Wang
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Complementary and Alternative Medicine
Subjects:
Cerebral ischemia-reperfusion injury
NLRP3 inflammasome
Chinese medicine
Qingkailing injection
Online Access:http://link.springer.com/article/10.1186/s12906-019-2703-5

Internet

http://link.springer.com/article/10.1186/s12906-019-2703-5

Similar Items